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ABSTRACT
Eberhardt, Scott F. Determining the Effectiveness of the Cancer Phase Training
Model in a Group Setting. Unpublished Master of Science, University of
Northern Colorado, 2017
The role of exercise as a primary therapy has been well documented and has the
capacity to act across multiple body systems to attenuate cancer-related toxicities. To
date, the Cancer Phase Training Model is the only cancer rehabilitation intervention that
includes recommended modes, intensity, frequency, and duration of exercise for cancer
survivors. The one-on-one model has been shown to be the most effective method of
cancer rehabilitation; however the largest perceived limitation of this model is the
expense of the program and its lack of scalability. By creating a structured cancerspecific group model that can produce similar results to the one-on-one model, we can
provide a feasible alternative rehabilitation program for cancer survivors. Purpose: To
evaluate the effects of the Cancer Phase Training Model in a group setting, on
cardiorespiratory endurance, muscular strength, and cancer related fatigue in cancer
survivors. Methods: A total of 14 cancer survivors participated in the group model,
with 12 participants completing the group model. The frequency of training was
prescribed as two sessions per week for 12 weeks. The duration of each exercise session
was 60 minutes with 20 minutes designated for cardiovascular exercise, 30 minutes for
resistance exercise, 10 minutes for flexibility training, and with balance exercises
incorporated throughout the entire session. Participants in the Group Model had a
designated time in which they could exercise under the direct supervision of a Cancer
iii

Exercise Specialist. Changes in peak volume of oxygen consumption (VO2peak),
muscular strength, and Cancer-Related Fatigue were observed once the 12 week
intervention was completed. Percent change in VO2peak, muscular strength, and fatigue
from data collected in the Individual Phase Training Model were compared to the data
collected in the Group Phase Training Model. Results: After completing a 12-week
intervention in the Group Model, significant improvements (p<0.05) were observed in
VO2peak, leg press muscular strength (MS), chest press MS, seated row MS, and shoulder
press MS, and fatigue. Although the GM was a pilot study and had a lower number of
participants, similar results between GM and the IM Phase Training Model were
observed in all variables. Participants completing the IM model resulted in an average
11% increase in VO2peak, while the GM resulted in an average 9% increase. Participant’s
leg press strength increased by an average of 9% in the IM compared to an average 10%
increase in the GM. Participant’s chest press strength increased by an average of 16% in
the IM, in comparison to an average 16% increase in the GM. The mean percent change
in fatigue for participants completing the IM as a 21% decrease, while the GM
experienced a 36% decrease in fatigue. Conclusion: This pilot study demonstrates that
the Phase Training Model protocol can be safely and effectively administrated in a group
setting. By offering the Phase Training Program in a group model, healthcare
professionals can have a greater impact by providing services to more cancer survivors
without placing the financial burden on the survivor or the program provider. By
demonstrating its diversity, the Phase Training Model should be considered as a standard
of care in the clinical cancer rehabilitation setting considering its success in both the
group and individual model.
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CHAPTER I

INTRODUCTION
There are over 15 million cancer survivors in the United States today, with
approximately 20 million survivors expected by 2026 (Miller et al., 2016). This increase
in survival rate is attributed to improvements in early detection of cancer along with the
advancement in cancer treatment. With an increase in survival rate, more cancer
survivors are suffering from side-effects as a result of radiation, chemotherapy, and
surgery. Although cancer treatments are effective in eliminating cancer, they lead to
debilitating side effects in up to 96% of cancer survivors (Schneider, Dennehy,
Roozeboom, & Carter, 2002). The toxicities from cancer treatment have detrimental side
effects on physiological and psychological aspects of the cancer survivor’s life.
The negative physiological side effects from treatment affect the cardiovascular,
immune, pulmonary, gastrointestinal, neuroendocrine, hepatic and musculoskeletal
systems (Schneider et al., 2002). The debilitating physiological side effects have a
significant impact on the negative psychological side effects, which include increased
fatigue and depression, and a decrease in quality of life (QOL). The role of exercise as a
primary therapy has been well documented and has the capacity to act across multiple
body systems to attenuate cancer related toxicities (Schmitz et al., 2010; Schneider et al.,
2002). Exercise training-induced improvements can be expected regarding aerobic
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fitness, muscular strength, QOL, and fatigue in survivors with many types of cancer
(Schmitz et al., 2010).
The beginning of cancer rehabilitation can be traced back to the National Cancer
Act of 1971, which involved a multidisciplinary team of providers, including physiatrists,
social workers, physical therapists and other medical personnel (Alfano, Ganz, Rowland,
& Hahn, 2012; DeLisa, 2001). Today, cancer survivors are spending less time recovering
in the hospital setting making these multidisciplinary services unnecessary for cancer
rehabilitation. Recent research has demonstrated that a one-dimensional approach using
exercise-based rehabilitation can affect the majority of the disabilities suffered by cancer
survivors (Schneider, Dennehy, & Carter, 2003). The American College of Sports
Medicine (ACSM) suggests that cancer survivors engage in 150 minutes of moderateintensity or 75 minutes of vigorous-intensity exercise per week and should avoid
inactivity. Adding that prescriptive exercise should be individualized according to a
cancer’s survivor’s aerobic fitness, medical co-morbidities, response to treatment, and
negative side effects of treatment that are experienced at any given time (Schmitz et al.,
2010). To date, the Cancer Phase Training Model introduced by Brown (2016) is the
only established, structured, individualized model for cancer rehabilitation that includes
mode, intensity, frequency and duration for cancer survivors throughout the cancer
continuum.
Although group and one-on-one model have been reported to be safe and effective
models for cancer rehabilitation (Dittus et al., 2015; Brown, 2016), current research is
lacking in providing a consistent structure for a cancer-specific group model. Research
shows that there are many benefits for cancer survivors working within a group,
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including decreasing the financial burden and positively influencing the outcome results
of a program offered (May et al., 2008, Midtgaard et al., 2005). The one-on-one model
has been shown to be the most effective method of cancer rehabilitation; however the
largest perceived limitation of this model is the expense of the program, not making it
feasible to offer to the masses. By creating a structured cancer-specific group model that
can produce similar results to the one-on-one model, we can provide a feasible alternative
rehabilitation program for cancer survivors.
Statement of Purpose
The purpose of this study was to determine if the UNCCRI Phase Program was
more effective in a group model setting or in a one-on-one setting. Effectiveness was
evaluated by determining changes in cardiorespiratory endurance, muscular strength, and
cancer-related fatigue. Establishing a cancer rehabilitation model that can be
administrated in an individual and group setting could provide adaptability for clinics and
hospitals administrating a cancer rehabilitation program. By creating a structured cancerspecific group model that can produce results similar to the one-on-one model, a feasible
rehabilitation program for the large number of cancer survivors could be provided. It was
hypothesized that the Cancer Phase Training Rehabilitation Program is more effective
with a one-on-one model when compared to a group model.
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CHAPTER II
REVIEW OF LITERATURE
Introduction
Cancer is a disease characterized by the uncontrolled growth and spread of
abnormal cells, affecting any organ or body part. This disease is the leading cause of
death in 22 states and second most common cause of death in the United States (US),
exceeded only by heart disease, and accounts for nearly 1 of every 4 deaths (Siegel,
Miller, & Jemal, 2016). The American Cancer Society (ACS) estimates that over 1.5
million new cancer cases are expected to be diagnosed in 2016, with nearly 600,000
people expected to die of cancer in 2016 (Siegel, Miller, & Jemal, 2016). The most
common types of cancer are prostate cancer among men and breast cancer among
women. Although the 2016 diagnostics number is higher than ever before, cancer
survival rates continue to increase each year. The 5-year survival rate for all cancers
diagnosed during 2005-2011 was 69%, which is up 20% from the 49% survival rate
during 1975-1977 (Siegel, Miller, & Jemal, 2016). There are over 15.5 million cancer
survivors in the US today; with 18 million survivors expected by 2022 (Miller et al.,
2016). This increase in survival rate is attributed to the increase in early detection of
cancer along with advancements in cancer treatment.
With an increase in survival rate, more cancer survivors are suffering from
toxicities as a result from treatments such as radiation, chemotherapy, and surgery.
Although cancer treatments are effective in eliminating cancer, they lead to debilitating

5
side effects in up to 96% of cancer survivors (Schneider et al., 2002). The toxicities from
cancer treatment have harsh side effects on physiological and psychological aspects of
the cancer patient’s life. The negative physiological side effects from treatment affect the
cardiovascular, immune, pulmonary, gastrointestinal, neuroendocrine, hepatic and
musculoskeletal systems (Schneider et al., 2002). The debilitating physiological side
effects have a large influence on the psychological side effects, which include increased
fatigue, increased depression, and a decrease in quality of life (QOL). Although there are
specific risks associated with cancer treatment that need to be considered when cancer
survivors exercise, there is dependable evidence that exercise is safe during and after
treatment (Schmitz et al., 2010). Due to this, millions of cancer survivors in the US today
can benefit from a structured exercise program administered by a trained Cancer Exercise
Specialist. As the cancer rehabilitation field continues to grow, hospitals and outpatient
clinics are beginning to establish different types of exercise interventions including,
home-based exercise, group-based exercise, and one-on-one-based exercise interventions.
To date there is only one exercise intervention that is specifically designed with precise
prescriptive exercise involving all the basic principles of exercise and standardization of
exercise-based model for cancer patients, which is known as the Cancer Phase Training
Model (Brown, 2016).
Cancer Treatments
The most common treatments for cancer are chemotherapy, radiation, hormonal
treatment, and surgery. Alternative treatments involve immunotherapy, hyperthermia and
stem cell transplant (Siegel, Miller, & Jemal, 2016). The advancement in cancer
treatments is one of the crucial contributors to the increased survivorship of cancer
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patients. Cancer treatments can be used independently, but are often used in conjunction
with one another to help increase the chances of treating cancer.
Chemotherapy is the administration of antitumor drugs that destroy malignant
tumor cells. The goal of chemotherapy is to destroy tumor cells and minimize the
destruction of normal cells while limiting the disruption of normal cell function.
Chemotherapy is usually administrated orally in pill, capsule, or liquid form, or via vein
or artery infusion, having an effect on the entire body. The antineoplastic effects of
chemotherapy are most pronounced in cells during the proliferation phases of the cell
cycle. Because cancer cells proliferate faster than normal cells, chemotherapy drugs
destroy a higher percentage of cancer cells than normal cells (Schneider, Dennehy, &
Carter, 2003). There are different classifications of chemotherapy that attack cancer cells
differently. The classes of chemotherapy include alkylating agents, antimetabolites,
antitumor antibiotics, and alkaloids (Greenhalgh & Symonds, 2014).
Radiation therapy uses high-energy X-rays, electron beams, or radioactive
isotopes to damage and destroy malignant cancer cells (Schneider et al., 2003).
Unfortunately, like chemotherapy, radiation cannot differentiate between normal cells
and cancer cells, negatively affecting both cancerous and normal cells that come in
contact with the radiation. The response to radiation in normal and cancer cells depends
on the rate of cell proliferation (Kerr, Winterford, &Harmon, 1994). The two most
common types of radiation therapy used are internal and external radiation. External
radiation aims beams of radiation from a source outside the body at the targeted tissue
within the body; while internal radiation places radioactive isotopes near the tumor within
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the body (Greenhalgh & Symonds, 2014). The main use of radiation is to target small
areas of the body and would not be used for metastasizing cancers (Kerr et al., 1994).
Surgery can be a safe and effective method of removing cancer in patients with
solid tumors that are confined to one tissue of organ (Schneider et al., 2003). Not only
can surgery be effective in removing cancer but is also used for prevention and diagnosis
of cancer. Surgical treatment aims to remove the cancerous tumor cells and some
surrounding healthy tissue while causing minimal injury to normal functioning of the
affected area (Schneider et al., 2003).
Treatment Side Effects
The adverse effects of cancer treatment may be immediate, resolving during a
period of days or weeks, or may be persistent, lasting years after the completion of
treatment (Schmitz et al., 2010). Treatment side effects are patient-dependent, meaning
that even though two different patients may have the same diagnosis and treatment, their
side effects to can differ greatly. The impact of cancer treatment is not limited to cancer
cells but also causes deleterious effects on healthy tissues that result in physiological and
psychological negative side effects in cancer survivors (Schneider, Hsieh, Sprod, Carter
& Hayward, 2007a). The side effects from cancer treatment can affect the
cardiovascular, pulmonary, immune and musculoskeletal systems, which can lead to
fatigue, depression, and decreased QOL.
Cardiovascular Toxicities
Both chemotherapy and radiation therapy have adverse effects on the
cardiovascular system. Chemotherapy directly damages cardiac myocytes, resulting in a
loss of myocardial fibrils, mitochondria changes, and cellular destruction within the

8
cardiac tissue (Camp-Sorrel, 2006). Chemotherapy-induced cardiovascular toxicities
may include cardiomyopathy with or without overt congestive heart failure, endothelial
dysfunction, and arrhythmias (Carver et al., 2007). Radiation has a large effect on the
cardiovascular system when external beam radiation is used on the thoracic region.
Radiotherapy-induced cardiovascular toxicity may include coronary artery disease,
valvular heart disease, chronic pericardial disease arrhythmias and conduction
disturbances cardiomyopathy or carotid artery stenosis (Carver et al., 2007). These
cardiovascular toxicities can result in left ventricular dysfunction, increased time to peak
filling of the left ventricle, lower left ventricular ejection fraction, abnormal left
ventricular contractility, reduced cardiac output and stoke volume, which may lead to
lower oxygen and nutrient delivery (Schneider et al., 2007a). The incidence of abnormal
cardiac function appears to increase with accumulation of time after treatment, and in
patients with a higher total cumulative dose of chemotherapy and radiotherapy (Carver et
al., 2007).
Pulmonary Toxicities
Cancer patients undergoing cancer treatment may experience acute or chronic
pulmonary toxicities. Pulmonary toxicities include radiation pneumonitis, pulmonary
fibrosis, and an overall decrease in pulmonary function (Carver et al., 2007).
Chemotherapy causes its initial damage to endothelial cells, causing extensive alterations
of the pulmonary parenchyma, with changes in the connective tissue, obliteration of
alveoli, and dilation of air spaces (Camp-Sorrel, 2006). Radiation destroys the cells
lining alveoli, and the alveoli become inflamed with accumulated exudative fluid (CampSorrel, 2006). Patients may experience coughing, dyspnea, and a low grade fever as a
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result of pulmonary toxicity (Schneider et al, 2002). These changes in pulmonary
function result in shortness of breath, decrease total lung capacity, decrease diffusion
capacity, which in turn compromises oxygen delivery and carbon dioxide removal
(Schneider et al., 2007a). These pulmonary toxicities may present as symptoms such as
fatigue, low exercise tolerance, and restlessness.
Musculoskeletal Toxicities
The side effects from cancer treatment have negative impacts on the muscular
system, which can be a direct effect of the cancer treatment itself along with other side
effects from treatment. Cancer and cancer treatment can induce lean tissue degradation
and abnormalities in the metabolic system in skeletal muscle, resulting in muscle wasting
and a decrease in muscular strength in cancer survivors. This loss in lean muscle occurs
due to a decline in protein synthesis in conjunction with enhanced protein catabolism
(Schneider, Hsieh, Sprod, Carter & Hayward, 2007b). The decrease in protein synthesis
and protein degradation reduces muscle mass and muscle fiber cross-sectional area, it
results in the loss of muscle extensibility, and it decreases proteins necessary for
metabolism. Cancer survivors with reduced protein synthesis and enhanced muscle
degradation experience muscle weakness, decrease functional work capacity, decreased
flexibility, and reduced mobility (Schneider et al., 2007b). Radiation has also been found
to alter the sarcolemma, sarcoplasmic reticulum, and mitochondrial membrane, leading to
the disturbances in generating muscle force. This loss of muscle force is a result of the
abnormalities in the recycling of calcium (Ca2+) by the sarcoplasmic reticulum and
abnormalities in the calcium-adenosine triphosphatase (Ca2+-ATPase) system (Schneider
et al., 2002).

10
Fatigue
Fatigue is recognized as the most pervasive and debilitating adverse effect in
cancer survivors (Hofman, Ryan, Figueroa-Moseley, Jean-Pierre, & Morrow, 2007;
Lawrence, Kupelnick, Miller, Devine, & Lau, 2004). Cancer-related fatigue (CRF)
varies greatly from fatigue of everyday life, which is usually temporary and is relieved by
rest. The definition of CRF is an overwhelming, draining, whole-body tiredness that is
unrelated to activity or exertion, and negatively impacts overall well-being and activities
of daily living, that are not alleviated by rest (Brown 2016). Hofman et al. (2007)
reported that 40% of patients at diagnosis, up to 90% of patients treated with radiation
and 80% of patients treated with chemotherapy experience cancer related fatigue.
Cardiotoxicity, pulmonary toxicity, musculoskeletal toxicity, and other physiological
toxicities resulting from treatment may all result in CRF (Schneider & Hayward, 2013).
Cardiovascular toxicities may reflect a decreased stroke volume and cardiac output,
which would cause a decrease in oxygen and nutrient delivery to tissues and organs,
placing more stress on the heart, leading to fatigue. Pulmonary toxicities have a similar
effect causing a decrease the amount of oxygen diffusion and lung capacity due to
pulmonary fibrosis. The decrease in oxygen diffusion also contributes to the decrease in
oxygen delivery throughout the body. A decrease in protein synthesis may contribute to
muscle toxicities, resulting in a decrease in cross-bridge formation and muscle
contraction, contributing to a decrease in strength and an increase in the sensation of
fatigue. Fatigue not only affects physiological systems, it also has a significant impact on
cancer survivor’s psychological state of mind, including mood, anxiety, and depression
(Curt et al, 2000).
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Depression
Depression is one of the most common psychological side effects of cancer and
cancer treatment, affecting 10% to 25% of all cancer survivors (Pirl, 2004). The most
common symptoms of depression are negative mood along with low energy, poor
concentration, loss of interest, memory disturbances, low self-esteem, guilty feeling,
hypochondriac preoccupation, sleep and appetite disturbances and hopelessness (Pasquini
& Biondi 2007). The severity of depression fluctuates depending on the type of cancer,
the stage of cancer, cancer treatment, and coping strategies of the patient (Schneider et
al., 2002). Depression in cancer survivors should be monitored carefully because it can
affect the patient’s QOL, it can exacerbate inactivity, and it can influence the outcome of
treatment (Pirl, 2004).
Quality of Life
Quality of life is a term used widely to describe an individual’s assessment of
their own well-being, including symptoms and functioning in physical, psychological,
social, and spiritual domains (Hewitt, Greenfield, & Stovall, 2005). Multiple studies
have documented that cancer diagnosis and cancer treatments have negative effects on
patients overall QOL both during and after treatment (Hendren et al., 2012). These
effects can be attributed to the cardiovascular, pulmonary and musculoskeletal toxicities
that result in an inability to complete basic activates of daily living.
Benefits of Exercise
Through the advancement in cancer detection and treatment the multidisciplinary
services of the National Cancer Act of 1971 (Alfano et al., 2012) may no longer be
necessary for cancer rehabilitation. Resent research has demonstrated that a

12
unidimensional approach using exercise-based rehabilitation can affect the majority of
the disabilities experienced by cancer survivors. The role of exercise as a primary
therapy has been well documented and has the capacity to act across multiple body
systems to attenuate cancer-related toxicities (Schmitz et al., 2010; Schneider et al.,
2002).
Although there are specific risks associated with cancer treatment that need to be
considered when survivors exercise, there is consistent evidence that exercise is safe and
effective during and after cancer treatment (Schmitz et al., 2010). Exercise has been
established as a successful method of rehabilitation for improving both physiological and
psychological side effects cancer survivors’ experience. Exercise training-induced
improvements can be expected in aerobic fitness, muscular strength, QOL, and fatigue in
many types of cancer survivors (Schmitz et al., 2010).
When analyzing the effects of exercise on cancer toxicities, cardiovascular and
pulmonary toxicities are usually group into one category, cardiorespiratory. Acute and
chronic exercise can enhance the cardiorespiratory system. The physiological changes
that occur through exercise reduces stress on the heart and blood vessels, thus enhancing
the ability of the heart and lungs to more efficiently deliver oxygen to the working tissues
(Schneider et al., 2002). These changes improve cardiovascular efficiency, increase
cardiac output and stroke volume, decrease resting heart rate, lower exercise heart rate
and improve ventilation and transport of oxygen (Schneider et al., 2007a). Improvements
in the pulmonary system include an increase in forced vital capacity, forced expiratory
volume, predicted maximal oxygen consumption, and the length of time on the treadmill
(Schneider et al., 2007a). These benefits of exercise have the potential to reverse or
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attenuate the cardiorespiratory toxicities experienced by cancer patients. Research
indicates that relatively short-term, structured, moderate-intensity exercise training
significantly improves VO2peak in cancer patients both during and following adjuvant
therapy (Jones et al., 2011).
Exercise improves the efficiency of skeletal muscle cells to preform contractions,
alleviating the effects of muscle wasting and decreased strength experienced by cancer
patients (Schneider et al., 2003). The changes occur through an increase in the number
and size of mitochondria, increased ability to resynthesize adenosine triphosphate (ATP),
increased myoglobin, increased protein synthesis, and increased muscle fiber crosssectional area (Schneider et al., 2007a).
The positive physiological outcomes from a proper exercise intervention have a
large effect on increasing patient’s psychological variables including fatigue, depression
and QOL. Regular physical exercise improves mood, body image, self-concept, and
sleep patterns, resulting in decreased anxiety, depression and feeling of helplessness in
cancer patients (Schneider et al., 2003). Research indicates that cancer patients
participating in a supervised exercise intervention have significantly reduced levels of
fatigue when compared to a control group (Carayol et al., 2013; Puetz & Herring, 2012)
with one study reporting 32-39% decreases in fatigue scores (Schneider, & Hayward,
2013). With a strong correlation between fatigue and depression severity, improvements
can also be seen in depression following an exercise intervention. Patients who exercise
during treatment can experience a 43% decrease in depression, while participants
exercising following treatment report a 25% decrease. With an increase in physiological
variables along with a decrease in fatigue and depression, QOL significantly increases.

14
Blanchard et al. (2003) reported that promoting exercise three days per week is suggested
in order to experience optimal increases in QOL.
Physical Activity vs. Prescribed Exercise
Research indicates that physical activity or an exercise intervention can positively
affect the physiological and psychological side effects of cancer treatment and inactivity
should be avoided (Schmitz et al., 2010). When reviewing the exercise programs created
for cancer patients, programs should be split up into physical activity and prescriptive
exercise. Physical activity is defined as any body movement produced by skeletal
muscles that requires more energy expenditure than resting (Caspersen, Powell, &
Christenson, 1985), such as walking, running, swimming, yoga and gardening. The
American College of Sports Medicine (ACSM) suggest that cancer survivors engage in
150 minutes of moderate-intensity or 75 minutes of vigorous-intensity exercise per week
(Schmitz et al., 2010). However, these guidelines are very broad and fall within the
definition of physical activity. ACSM added that prescriptive exercise should be
individualized according to a cancer survivor’s aerobic fitness, medical comorbidities,
response to treatment, and negative side effects of treatment that are experienced at any
given time (Schmitz et al., 2010). These considerations emphasize the need for
prescriptive exercise interventions when working with cancer patients. Prescriptive
exercise refers to specific exercise guidelines prescribed for an individual that are
designed for a specific purpose or purposes.
If one is to expect specific outcomes from therapeutic exercise interventions, it is
necessary to prescribe exercise using the fundamental principles of exercise such as
specificity, progression, overload, initial values, reversibility and diminishing returns

15
(Winter-Stone, Neil, & Campbell, 2013). When comparing different types of exercise
interventions designed for cancer patients, it is very important that programs follow these
principles to take into account the cancer patients physiological and psychological
alterations during and after treatment. The most popular exercise interventions for cancer
patients include home-based interventions, group interventions, and individual one-onone interventions (Blaney et al., 2010). Unfortunately, there are only a hand-full of
exercise models that address the majority of the principles of exercise. Of the hand full
of exercise interventions, all but one lacks the appropriate assessment, prescription, and
interventions needed to directly target the toxicities caused by cancer treatments. Homebased exercise interventions for cancer patients often recommend modes of physical
activity such as walking or yoga, and do not fall within the principles of exercise.
Although home-based exercise interventions may have positive effects on the
physiological and psychological aspects of a cancer survivor’s life, not adhering to the
principles of exercise does not make it a valid unidimensional mode of cancer
rehabilitation. The only possible way to properly administer a prescriptive exercise
intervention is under the supervision of a Cancer Exercise Specialist (CES) in either a
group or individual setting. With the increasing number of possible exercise
interventions available, it is important to determine whether a group or individual model
is more effective when administering a rehabilitation program in a hospital or outpatient
setting.
In the apparently healthy population, group exercise means having one exercise
professional leading a group through a series of exercises performed all together
throughout a session. The group class is not specifically designed for every individual in
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the group but focuses on increasing general physiological aspects of fitness. Most group
classes are held at certain times and participation is not mandatory. However, the term
“group” has a different meaning in exercise-based cancer rehabilitation when compared
to the general public’s view of group exercise. A group-based cancer rehabilitation
intervention is classified as two or more participants that are able to attend a reserved
time in a facility where cancer patients can come in and complete a specifically designed
individual workout under supervision of an exercise professional or physical therapist.
Not only do cancer survivors have an individual workout but frequency, intensity and
time are all prescribed in each workout. Cancer group exercise is also a prescribed
amount of time to complete the program. After a cancer survivor has completed their
program they will be re-tested and prescribed a new exercise regimen with new
frequencies, intensities, and time, based on their assessment results. During the allotted
time for group exercise cancer survivors are encouraged to complete as many exercises as
possible during their allotted time.
The group-based cancer rehabilitation intervention has been a popular model in
many hospitals and clinics. While both group and one-on-one exercise interventions
have been established as safe and effective for cancer patients, there are many benefits
that come from working within a group. Not only can a group model decrease the
financial burden on cancer survivors, it may also result in positive program outcomes
(May et al 2008, Midtgaard et al, 2005). Braney et al. (2010) conducted a qualitative
study illustrating that most participants would prefer exercising with other patients with
cancer within a clinic or hospital setting, as they would have similar cancer experiences
and comparable fitness levels.
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The University of Vermont recently published parameters for a group-based
cancer rehabilitation intervention that is based off a cardiac rehabilitation model. Dittus et
al. (2015) proposed a three phase program that separates cancer survivors whether they
are in or out of treatment and the time in which they have completed cancer treatment.
Phase 1 addresses range of motion defects and deconditioning after surgery while
receiving cancer treatment, working one-on-one with a physical therapist transitioning to
independent exercise. Phase 2 consisted of structured group, medically supervised
exercise immediately after cancer treatment, addressing persistent side effects and
deficits, supervised exercise progression, and lifestyle improvements. Phase 3 was
characterized as independent group exercise to improve fitness and lifestyle interventions
to improve chronic disease management. In this study the only phase that can be
classified as cancer rehabilitation group exercise is Phase 2. In this phase patients are
prescribed specific frequency, intensity and time, based off of the cancer survivor’s
fitness assessment. Phase One of this program is working with a physical therapist to
make sure the survivor has normal range of motion, while Phase 3 in this study is
classified as apparently healthy group exercise, neither Phase 1 or Three incorporate the
principles of exercise. Phase 2 of this program was a cancer rehabilitation group design
with individuals exercising in a less supervised fashion, with an exercise physiologist
available if needed. The group intervention for Phase 2 consisted of two days a week of
aerobic and resistance training. The training program included twenty minutes of aerobic
training at 70%-80% peak heart rate or between a RPE of twelve and fourteen. The
resistance training included upper and lower extremity exercises with the intensity set at
60%-70% of one repetition maximum or able to complete eight repetitions with good
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form. Data collected from Phase two throughout the 12 week program showed an 8%
increase in VO2peak, 22% increase in chest press one rep max, 22% increase in leg press
one rep max, 36% decrease in fatigue, 25% decrease in depression and 19% decrease in
anxiety (Dittus et al. 2015). Throughout their prescriptive exercise they adhered to all
principles of exercise. The limitations of this program are the methods used to obtain
baseline results and that the design of the program was developed for cardiac patients
rather than cancer survivors. However, this program illustrated that group-based cancer
rehabilitation is safe for cancer patients to perform and has positive effects on the
physiological and psychological side effects of cancer treatment.
In contrast, the University of Northern Colorado Cancer Rehabilitation Institute
(UNCCRI) created the first individual one-on-one model designed specifically for cancer
survivors (Schneider et al., 2002). This model utilizes a four phase program that is
classified by what point on the cancer continuum the cancer survivor falls in. Phase 1
individuals are classified as patients currently in treatment (chemotherapy and/or
radiation). Phase 2 individuals are patients who have never received chemotherapy or
radiation, who have completed chemotherapy or radiation treatment, or have completed
Phase 1. Phase 3 are patients who have completed phase two, and phase four are patients
completed with phase three. The Cancer Phase Training Model uses cancer-specific
physiological and psychological assessments to create specific, individualized
prescriptive exercise interventions. Each Phase has different exercise intensities and
goals that are based off of the initial assessment of each participant. Phase 1 intensities
may be classified as low, ranging between 30-45% heart rate reserve (HRR) and
estimated one repetition maximum (EST 1-RM). Phase 2 intensities may be classified as
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low to moderate ranging 40-60% HRR and EST 1-RM. Phase 3 intensities may be
classified as moderate to high and range between 60-85% HRR and EST 1-RM. The
frequency of training was prescribed as three sessions per week for twelve weeks. The
duration of each exercise session was sixty minutes with twenty minutes designated for
cardiovascular exercise, thirty minutes for resistance exercise, ten minutes for flexibility
training, and with balance exercises incorporated throughout the entire session. From the
data collected, Phase 1 participant’s results showed a 13% increase in VO2peak, 8%
increase in leg press one rep max, 16% increase in chest press one rep max, and a 27%
decrease in fatigue. Phase 2 participants results showed a 15% increase in VO2peak, 16%
increase in leg press one rep max, 23% increase in chest press one rep max, and 27%
decrease in fatigue. Phase 3 participants results showed a 5% increases in VO2peak, 4%
increase in leg press one rep max, 8% increase in chest press one rep max, and a 8%
decrease in fatigue (Brown, 2016). As previously mentioned this is the first exercise
program that included all the basic principles of exercise and cancer specific assessments
to properly prescribe a therapeutic exercise intervention tailored specifically for cancer
patients.
The purpose of this study was to determine if the UNCCRI Phase Program was
more effective in a group model setting or in a one-on-one setting. Effectiveness was
evaluated by determining changes in cardiorespiratory endurance, muscular strength, and
cancer-related fatigue. Establishing a cancer rehabilitation model that can be
administrated in an individual and group setting could provide adaptability for clinics and
hospitals administrating a cancer rehabilitation program. By creating a structured cancerspecific group model that can produce results similar to the one-on-one model, a feasible
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rehabilitation program for the large number of cancer survivors could be provided. It was
hypothesized that the Cancer Phase Training Cancer Rehabilitation Program is more
effective with a one-on-one model when compared to a group model.

21

CHAPTER III
METHODOLOGY
Participants
Data were obtained from subjects participating in the Cancer Phase Training
Group Model (GM) from during the 2016 calendar year. All participants were eligible
for participating in the group study if they were cleared to participate in an exercise
program through a referral by his/her oncologist or primary care physician. Participants
had to be able to move freely around the facility with minimal assistance and did not
require spotting while walking. Participants that required a walker to move around the
facility were excluded from the group study.
Participants were both male and female cancer survivors who were currently
undergoing or had completed cancer treatment including surgical intervention,
chemotherapy, radiation therapy, immunotherapy, hormonal therapy, and/or other types
of unconventional treatment. Safety of the participants was ensured throughout all data
collection, exercise testing, and exercise training through supervision by a CES. Along
with the referral from the physician or oncologist, a detailed medical and cancer history
of each participant was provided. Prior to any data collection, all participants were
informed that they were volunteers and could terminate their involvement in the study at
any time. Subjects entered into the program with a rolling enrolment, meaning they
could start their twelve week program once they signed up and did not have to wait for a
specific start date. After a thorough explanation of the group program, each participant
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agreed to participate and signed an informed consent. All protocols used for the study
were approved by the University of Norther Colorado’s (UNC) Institutional Review
board (Appendix A). All exercise testing and training took place at UNCCRI on the
University of Northern Colorado campus in Greeley, Colorado.
Recruitment
Participants were recruited into the group study from cancer patients that were
referred by their oncologist or primary care physician to participate in an exercise
intervention at UNCCRI. Participants were notified about the GM in the initial call from
UNCCRI after receiving their referral to schedule their initial assessment. One incentive
of a subject to participate in the GM was that the price for a twelve week intervention
was reduced compared to participating in the individual protocol. Another incentive for
subjects was that they would be exercising with other cancer survivors that they could
socialize with throughout the program. The GM was only offered at UNCCRI on
Tuesday and Thursday at 8 am and 11 am. Once a participant signed up for the group
model they were asked to pick either of the designated times to attend throughout the 12week program. If participants had a scheduling conflict for treatments or medical
appointments they were given the opportunity to attend an alternate time during those
days. One limitation to the GM was the schedule was that the times offered had to fit
within the participants’ schedule in order to participate in the GM.
Patient Screening and Paperwork
After receiving the participant’s physician referral and signed consent form, each
subject was asked to complete questionnaires evaluating their psychological function,
lifestyle, behavior, and medical information. All questionnaires were completed at the
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subject’s home prior to their initial assessment. The questionnaires included: Medical
History, Revised Piper Fatigue Scale, Beck Depression Inventory questionnaire, and
Ferrans and Powers Quality of Life Index Version III.
Medical History
Participants’ medical information was obtained via this self-reported worksheet
detailing present medical history, family medical history, medications, allergies, and
cancer diagnosis. If needed, further medical information was requested from the
participants’ oncologist or primary care physician.
Revised Piper Fatigue Scale
Fatigue was measured via the Piper Fatigue Inventory, which evaluates total
cancer-related fatigue, as well as four subscales of fatigue: behavior/severity, affective
meaning, sensory, and cognitive/mood. These individual subscales comprise 22
questions to help calculate each subscale and a score representing total fatigue. In order
to calculate fatigue on each subscale the sum of each subscale is taken and divided by the
number of items on that subscale. To calculate the total fatigue, all twenty questions
were added together and divided by twenty two. The fatigue scale ranges from zero to
ten, a score of zero indicates that the participant shows no sign of fatigue, a score from
one to three indicates mild fatigue, four to six indicates moderate fatigue, and a score
greater than or equal to seven indicates severe fatigue (Piper et al, 1998).
Beck Depression Inventory
This questionnaire is a valid and reliable (Vodermaier, Linden, & Siu, 2009) 21question index that assessed symptoms such as, but not limited to hopelessness, feelings
of being punished, weight loss, and guilt. Each question is rated on a four point scale
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ranging from zero to three based on the severity of each item. The sum all the rated
questions are taken to determine the individual’s depression, with a maximum total score
of 63. The higher the score indicate more severe depression with 0 indicating no
depression and >40 indicating extreme depression.
Ferrans and Powers Quality of Life Index Version III
This 66-question questionnaire is designed to evaluate social, psychological,
family and health satisfaction as well as total QOL. Higher scores indicate greater
satisfaction in QOL (Ferrans & Powers, 1985).
Prior to the initial assessment and each subsequent reassessment, a detailed
medical and cancer screening was recorded on the Client Summary form. The Client
Summary listed all pertinent cancer information, including type, stage and diagnosis date,
cancer treatments received or currently receiving, additional medications concerns that
may affect training, disease concerns, including family health history, current
medications, current and past physical activity level, and short and long term goals.
Assessment Protocols
Prior to the design of the participants’ prescriptive exercise, each participant
completed an Initial Assessment. Each assessment measured vitals, body composition,
cardiovascular endurance, muscular strength, and flexibility and range of motion (ROM).
Results from the assessment were recorded on the Data Collection Sheet for the
corresponding Phase. Reassessment occurred after each twelve week exercise
intervention completed by the participant.
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Vital Measurements
Prior to and following the completion of exercise testing, participants’ heart rate
(HR), oxygen saturation (SpO2), and blood pressure (BP) were assessed via heart rate
monitors around the chest, pulse oximeter, and sphygmomanometer and stethoscope,
respectively.
Body Composition
Body fat percentage was first assessed via the three-site skinfold (SKF) test using
a Lange skin fold caliper. The three-site SKF locations for men were: the chest, abdomen,
and thigh. The three-site SKF locations for women were: the triceps, suprailiac, and
thigh. Two measurements, in a rotational order, were taken; a third was taken at any site
that differed by more than two millimeters. Waist-to-hip ratios were measured in inches
using a tape measure at the slimmest point on their waist and the widest point on their
hip.
Cardiovascular Endurance
Cardiovascular endurance was evaluated using the cancer-specific UNCCRI
Treadmill Protocol, which yields VO2peak values. This protocol was found to be the most
accurate and appropriate for the cancer population (Shackelford, Brown, Peterson,
Schaffer, & Hayward, 2015). The goal of this test was for the participant to reach selfperceived maximal exertion or fatigue. The highest measurement of oxygen consumption
was calculated. This protocol consists of one minute stages, which increased speed and/or
incline at the conclusion of every stage. During the test, HR and SpO2 were collected at
the end of every minute. BP was recorded at the end of every three minutes, as well as the
participant’s rating of perceived exertion (RPE) on the modified Borg Scale. This RPE
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scale consisted of numbers zero to ten which correlates to the participants’ perceived
intensity of the test. An RPE of zero correlates with the intensity of a stroll in the park,
and a RPE of ten signifies the patient has reached his or her maximal effort and cannot
continue. The use of handrails was discouraged, but was allowed if deemed necessary. If
necessary, handrail usage was required throughout the entire test in order to stay
consistent. Termination criteria of the test were: participant reached volitional fatigue or
asked to stop for any reason, failure to increase systolic BP or HR with increased
intensity, fluctuation of more than 10 mmHg from resting measures in diastolic BP, or
oxygen saturation drops below 80 on the pulse oximeter. Once the testing ended, each
subject completed a cool-down period, where all of the aforementioned variables were
measured in the same manner as during the test. Final treadmill time, BP, HR, and RPE
was recorded. Peak volume of oxygen consumption was estimated using ACSM’s
walking and running equations, which have been found to be valid in determining
VO2peak (Shackelford et al., 2015).
Muscular Strength Assessment
Muscular strength was assessed via the estimated 1-repetition maximum protocol
(EST 1-RM) using the Brzycki equation. This test used Cybex Eagle resistance machines
(Cybex Inc., Medway, MA), and specifically utilized the following machines: chest press,
lat pulldown, seated row, shoulder press, leg press, leg curl, and leg extension. The goal
of this test was to have the participant lift as much weight as possible between one and
ten repetitions. RPE values were asked at the end of every set. The test was performed in
six steps as follows: (1) before the participant began the test, the CES demonstrated how
to perform each machine correctly with proper form, and adjusted the machine to ensure
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a proper fit for each participant. (2) The participant was then asked to perform a warm-up
set, which consisted of five repetitions at a low intensity. (3) After the warm-up set, the
weight was increased accordingly to elicit muscular failure or fatigue between 1 and 10
repetitions. (4) The participant then attempted to lift the weight deemed appropriate to
elicit failure between one to ten repetitions. (5) If the weight appeared to be too light to
elicit failure between one to ten repetitions, the set was stopped immediately and the
weight increased. If the weight was too heavy for even one full repetition, the weight was
reduced accordingly. (6) After a two to three minute rest, steps four and five may have
been repeated up to two times per machine to elicit a weight that resulted in muscular
fatigue between one and ten reps. The EST 1-RM values, as pounds (pounds) lifted, were
recorded for each machine.
Flexibility and Range of Motion Assessment
The modified sit-and-reach (SR) test, back scratch test, and reaching tests were
used to assess flexibility and range of motion. For the modified SR test, the participant
was instructed to sit on the floor with his or her shoulders, head, and hips against a wall.
The legs were extended in front of them, with their feet flat against a twelve inch SR box.
The participant then extended his or her arms out, with one on top of the other. The end
of the arm of the SR box was positioned so it was at the end of the participant’s
fingertips. The participant was instructed to bend forward at the hips and slide the
fingertips along the arm of the SR box until no further extension was possible. The value
was recorded in inches. This procedure was conducted two additional times, and the
highest value recorded.
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The back scratch test required the patient to reach up and behind their back with
the dominant hand, palm facing the back. They were asked to reach the other arm down
and behind the back as far as possible, with the palm facing away from the back. Both
wrists were kept as straight as possible. The distance between each middle finger was
used as landmarks and the distance in inches recorded. If the fingertips touched without
overlapping, the score was recorded as zero inches. If they did not touch, the score was
recorded as a negative value in centimeters, and if they overlapped it was recorded as a
positive value in centimeters.
For the reaching tests, the participant was asked to reach as far as possible with
both arms in the anterior plane, and then the sagittal plane. Arms were kept as straight as
possible. The highest score in each plane (anterior: 1 to 4; sagittal: 1 to 8) was recorded.
Phase Training Model: Prescriptive Exercise
Prescriptive exercise took place following the assessment and was created using
the Client Overview document. The Client Overview indicated the starting Phase, and
starting target intensity of both the aerobic and resistance training components of the
program. The participant screening, which was recorded on the Client Summary, and the
data collected from each assessment protocol, which was recorded on the Data Collection
Sheet, were used together to create the prescriptive exercise for each participant. If the
subject was currently undergoing chemotherapy and/or radiation therapy, he or she was
placed in Phase I. If treatment had ended at entry into the program or if the subject
underwent surgical intervention and/or other treatments (hormonal, immune, etc.), he or
she was placed in Phase II. The assessment results and specifically the classifications
achieved by the participant during each assessment were utilized to begin the process of
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selecting the appropriate target intensity of the intervention. The Client Summary further
assisted the prescription of intensity as the principles of individualization and specificity
were utilized in relation to each patient’s specific goals and desired outcomes from the
program.
Exercise Intervention
All exercise sessions were completed at UNCCRI under supervision of a CES.
There was one CES working with the group throughout its duration, who recorded all
physiological data. In the healthy population, group exercise means having one exercise
professional leading a group through a series of exercises performed all together
throughout a session. The group class is not specifically designed for every individual in
the group but focuses on increasing general physiological aspects of fitness. However,
the term “group” has a different meaning in exercise-based cancer rehabilitation when
compared to the general public’s view of group exercise. A group-based cancer
rehabilitation intervention is classified as two or more participants that are able to attend
a reserved time in a facility where cancer patients can come in and complete a
specifically designed individual workout under supervision of an exercise professional or
physical therapist. The beginning of a group-based intervention includes an orientation,
where participants are introduced to the exercises and proper use of the equipment for the
first week. Once the intervention begins the exercise professional takes more of a
supervising role only helping to increase intensity and assist if there are any questions.
Cancer survivors are encouraged to complete as many exercises as possible during their
allotted time.
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The frequency of training was prescribed as two sessions per week for twelve
weeks. The duration of each exercise session was sixty minutes with twenty minutes
designated for cardiovascular exercise, thirty minutes for resistance exercise, ten minutes
for flexibility training, and with balance exercises incorporated throughout the entire
session. Participants used the following modes for the aerobic portion of the exercise
session; treadmill, recumbent cycle ergometer, upright cycle ergometer and NuStep. For
the resistance training, each session focused on a full body workout targeting all the
major muscle groups including, chest, back, lower body, and core, and utilized three sets
of ten repetitions for each exercise. By participating in the group model the majority of
all the resistance training was performed on Cybex resistance machines, additional
exercises were prescribed to each participant individually which included Thera band,
dumbbells, body weight, and resistance tubing. The flexibility portion used straps,
chairs, and steps to help focus on targeting all major muscle groups that were used during
the exercise session.
The intensity of the prescriptive exercise was directly based off of the individual’s
treatment status, assessment results and the starting Phase. Participants who were still in
treatment would enter the phase program in Phase I. The goal of Phase I was to maintain
or slightly increase the participant’s physiological and psychological values. Participants,
who have completed chemotherapy or radiation, or who had never received either of
these treatments, were prescribed to Phase II. Phase II is also the next Phase for
participants who have completed Phase I. Participants enter into Phase III only by
completing Phase II.
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The GM did not use heart rate monitors to record intensity during the aerobic
session, due to only having one CES accounting for multiple participants. Instead the
revised RPE scale (0-10) was used to prescribe intensity for the aerobic portion. The
starting intensity for Phase I was low, ranging between 30-45% EST 1-RM and an RPE
of 4-6. Phase 2 starting intensity was low to moderate, ranging between 40-60% EST 1RM and a RPE of 5-7. The starting intensity for Phase 3 was moderate to high, with
intensities ranging between 60-85% EST 1-RM and a RPE of 6-8. Phase 4 starting
intensity was moderate to near maximal, ranging between 65-95% EST 1-RM and a RPE
of 6-9. To ensure the principles of progression and overload were met throughout each
phase, participants were educated about these two key factors of the intervention and
were taught how to apply them to their intervention. Through this education, participants
were given the freedom to increase their weight and aerobic intensities and report back to
the CES to record the increases. If the CES did not receive self-reported increases from a
participant after three weeks of new intensities for their strength or aerobic training, the
CES would encourage the participant to increase their weight on the strength machines or
the speed or grade on the aerobic equipment.
Exercise Intervention Orientation
The first two days of the GM, survivors participated in an orientation of their
exercise program. Lacking the direct supervision of a CES for each participant, the main
goal of orientation was to understand the intensity and progression of their intervention as
well as the proper use and safety precautions of all equipment being used.
Day One Orientation: The first part of day one of the orientation had the
participant and Cancer Exercise Specialist review initial results along with the intensity in
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which the Cancer Exercise Specialist has prescribed for the participant. The
understanding of RPE scale was explained to make sure the participant had a clear
understanding for both cardiovascular RPE and muscular strength RPE. Progressive
overload was explained to the participant to make sure progress is accomplished
throughout the twelve weeks. Participants were given the freedom to increase their
weight throughout the twelve weeks; if the CES did not see any progress the CES would
suggest an increase in intensity in either cardiovascular endurance or muscle strength.
The second part of orientation consisted of machine orientation of the cardiovascular
equipment. During this time the participant was shown all the available options to
perform the cardiovascular aspect of the workout. How to properly get on and off the
machine, changing intensity and how to stop the machine immediately in case of an
emergency was reviewed.
Day Two Orientation: Day two consisted of a review of the cardiovascular
machines, as well as the muscular strength machine orientation. During the machine
orientation participants were shown how to properly use each piece of machine along
with the proper seat position on every machine. During this time, participants were able
to go over their prescribed weights on each machine and report to the CES if they felt like
it was an accomplishable weight to begin with. If participants were not able to safely
complete the prescribed weight the CES was able to make adjustments to determine the
appropriate starting weight. After completion of the two days of orientation, the
participant began their twelve week intervention.
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Statistical Analysis
Two related samples Wilcoxon Signed-Rank Test was utilized to examine if
significant differences occurred in cardiovascular endurance, muscular strength, and
fatigue. The following dependent variables were assessed: VO2peak, EST 1-RM of leg
press, EST 1-RM chest press, EST 1-RM seated row, EST 1-RM lat pull down, EST 1RM shoulder press and fatigue. With the low number of participants, pre and post results
of all completed phases were compared. Statistical analyses were performed using the
Statistical Package for the Social Science software package (SPSS, Chicago, IL).
Significance levels were set at p < 0.05.
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Introduction
There are over 15.5 million cancer survivors in the United States today; with 20
million survivors expected by 2026 (Miller et al., 2016). This increase in survival rate is
contributed to the increase in early detection of cancer along with the advancement in
cancer treatment. With an increase in survival rate, more cancer survivors are suffering
from toxicities as a result of radiation, chemotherapy, and surgery. Although cancer
treatments are effective in eliminating cancer, they lead to debilitating side effects in up
to 96% of cancer survivors (Schneider, Dennehy, Roozeboom, & Carter, 2002). The
toxicities from cancer treatment have detrimental side effects on physiological and
psychological aspects of the cancer survivor’s life.
The negative physiological side effects from treatment affect the cardiovascular,
immune, pulmonary, gastrointestinal, neuroendocrine, hepatic and musculoskeletal
systems (Schneider et al., 2002). The debilitating physiological side effects have a large
influence on the negative psychological side effects, which include increased fatigue and
depression, and a decrease in quality of life (QOL). The role of exercise interventions as
a primary therapy has been well documented and has the capacity to act across multiple
body systems to attenuate cancer related toxicities (Schmitz et al., 2010; Schneider et al.,
2002). Exercise training-induced improvements can be expected regarding aerobic
fitness, muscular strength, QOL, and fatigue in many types of cancer survivors (Schmitz
et al., 2010).
The beginning of cancer rehabilitation can be traced back to the National Cancer
Act of 1971, which involved a multidisciplinary team of providers, including physiatrists,
social workers, physical therapists and other medical personnel (Alfano, Ganz, Rowland,
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& Hahn, 2012; DeLisa, 2001). Through the advancement in cancer detection and
treatment, cancer survivors are spending less time recovering in the hospital setting
making these multidisciplinary services unnecessary for cancer rehabilitation. Recent
research has demonstrated that a one-dimensional approach using exercise-based
rehabilitation can affect the majority of the disabilities suffered by cancer survivors
(Schneider, Dennehy, & Carter, 2003). The American College of Sports Medicine
(ACSM) suggests that cancer survivors engage in 150 minutes of moderate-intensity or
75 minutes of vigorous-intensity exercise per week and should avoid inactivity. Adding
that prescriptive exercise should be individualized according to a cancer’s survivor’s
aerobic fitness, medical co-morbidities, response to treatment, and negative side effects
of treatment that are experienced at any given time (Schmitz et al., 2010). To date, the
Cancer Phase Training Model introduced by Brown (2016) is the only established
structured individualized model for cancer rehabilitation that includes mode, intensity,
frequency and duration for cancer survivors throughout the cancer continuum.
Although the group and one-on-one model have been established as safe and
effective models for cancer rehabilitation (Dittus et al., 2015; Brown, 2016), to date
research is lacking in providing a consistent structure for cancer specific group model.
Research shows that there are many benefits for cancer survivors working within a group,
including decreasing the financial burden on cancer survivors and positively influencing
the outcome results of a program offered (May et al., 2008, Midtgaard et al., 2005). The
one-on-one model has been proven to be the most effective method of cancer
rehabilitation; however the largest perceived limitation of this model is the expense of the
program, not making it feasible to offer to the masses. The purpose of this pilot study is
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to evaluate the effects of the Cancer Phase Training Model in a group setting, on
cardiorespiratory endurance, muscular strength, and cancer related fatigue in cancer
survivors. By creating a structured cancer specific group model that can produce similar
results to the one-on-one model, we can provide a feasible alternative rehabilitation
program for cancer survivors.
Methodology
Subjects
Data were obtained from subjects participating in the Phase Training Group
Model (GM) during the 2016 calendar year. Participants were both male and female
cancer survivors who were currently undergoing or had completed cancer treatment
including surgery, chemotherapy, radiation therapy, immunotherapy, hormonal therapy,
and/or other types of unconventional treatment. All participants were eligible for
participation in the group study if they were cleared to participate in an exercise program
through a referral by his/her oncologist or primary care physician. Participants had to be
able to move freely around the facility with minimal assistance and did not require
spotting while walking. Participants that required a walker to move around the facility
were excluded from the group study.
Participants were recruited into the group study from referrals by their oncologist
or primary care physician to participate in an exercise intervention at the University of
Northern Colorado Cancer Rehabilitation Institute (UNCCRI). Participants were notified
about the GM in the initial call from UNCCRI after receiving their referral to schedule an
initial assessment. The GM was only offered at certain times during UNCCRI’s daily
operations, and must have fit within the participants schedule to participate. Subjects
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entered into the program with a rolling enrolment, meaning they could start their twelveweek program once they signed up and did not have to wait for a certain start date. All
protocols used for the study were approved by the University of Northern Colorado’s
(UNC) Institutional Review Board (see Appendix A). All exercise testing and training
took place at UNCCRI on the University of Northern Colorado campus in Greeley,
Colorado.
Patient Screening and Paperwork
After receiving the participant’s physician referral and signed consent form, each
subject was asked to complete questionnaires evaluating their psychological function,
lifestyle, behavior, and medical information. All questionnaires were completed at the
subject’s home prior to their initial assessment. The questionnaires included: Medical
History, Revised Piper Fatigue Scale, Beck Depression Inventory questionnaire, and
Ferrans and Powers Quality of Life Index Version III.
Physiological Assessments
Prior to the design of the participants’ prescriptive exercise, each participant
completed an Initial Assessment. Each assessment measured vitals, body composition,
cardiovascular endurance, muscular strength, and flexibility and range of motion (ROM).
Prior to and following the completion of exercise testing, participants’ heart rate (HR),
oxygen saturation (SpO2), and blood pressure (BP) were assessed via heart rate monitors
around the chest, pulse oximeter, and sphygmomanometer and stethoscope, respectively.
Cardiovascular endurance was evaluated using the cancer-specific UNCCRI Treadmill
Protocol which yields VO2peak values (Shackelford et al., 2015). Muscular strength was
assessed via the estimated 1-repetition maximum protocol (EST 1-RM) using the Brzycki
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equation. This test used Cybex Eagle resistance machines (Cybex Inc., Medway, MA),
and specifically utilized the following machines: chest press, lat pulldown, seated row,
shoulder press, leg press, leg curl, and leg extension.
Exercise Prescription
Prescriptive exercise took place following the assessment and was created using
the Client Overview document. The Client Overview indicated the starting Phase, and
starting target intensity of both the aerobic and resistance training components of the
program. The participant screening, which was recorded on the Client Summary, and the
data collected from each assessment protocol, which was recorded on the Data Collection
Sheet, were used together to create the prescriptive exercise for each participant. If the
subject was currently undergoing chemotherapy and/or radiation therapy, he or she was
placed in Phase I. If treatment had ended at entry into the program or if the subject
underwent surgical intervention and/or other treatments (hormonal, immune, etc.), he or
she was placed in Phase II. Once a subject had completed Phase II and the reassessment,
subjects were then moved into Phase III of the Phase Training Model. The assessment
results and specifically the classifications achieved by the participant during each
assessment were utilized to begin the process of selecting the appropriate target intensity
of the intervention. Table 1 describes the criteria for the entry and transition in the Phase
Training Model and Phase intensity.
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Table 1
Phase Transitions and Intensities
Phase
Entry Criteria
1 Participants who are still in treatment
2 Have completed cancer treatment or receiving
hormonal treatment, or after the completion of
Phase 1
3 By completing Phase 2

Intensity
30-45% EST 1-RM and
an RPE of 3-5
40-60% EST 1-RM and
a RPE of 5-7
60-85% EST 1-RM and
a RPE of 6-8

Exercise Intervention
There was one Cancer Exercise Specialist (CES) working with the group
throughout its duration, who recorded all physiological data. The frequency of training
was prescribed as two sessions per week for twelve weeks. The duration of each exercise
session was 60 minutes with 20 minutes designated for cardiovascular exercise, 30
minutes for resistance exercise, 10 minutes for flexibility training, and with balance
exercises incorporated throughout the entire session. The intensity of the prescriptive
exercise was directly based on the individual’s treatment status, assessment results and
the starting Phase. The GM did not use heart rate monitors to record intensity during the
aerobic session, due to only having one CES accounting for multiple participants.
Instead, the revised RPE scale (0-10) was used to prescribe intensity for the aerobic
portion.
Orientation
The first two days of the GM, survivors participated in an orientation of their
exercise program. Lacking the direct supervision of a CES for each participant, the main
goal of orientation was to understand the intensity and progression of their intervention as
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well as the proper use and safety precautions of all equipment being used. All
orientations were performed one-on-one with the CES who was overseeing the group.
Day One Orientation: The first part of orientation reviewed the results of the
Initial Assessment along with the intensities in which the CES has prescribed for the
participant. Following this, each participant underwent an orientation of to the
cardiovascular equipment. During this time the participant was shown all the available
options to perform the cardiovascular aspect of the workout, this included treadmill,
upright and recumbent bike, and Nustep. How to properly get on and off the machine,
changing intensity and how to stop the machine immediately in case of an emergency
was reviewed. While on the cardiovascular machine RPE was reviewed in order for
participants to determine the speed and resistance of the appropriate intensity.
Day Two Orientation: Consisted of a review of the cardiovascular machine, as
well as the muscular strength machine orientation. During the machine orientation
participants were shown how to properly use each piece of machine along with the proper
seat position on every machine. After completion of the two days of orientation, the
participant began their twelve week intervention
Statistical Analysis
A two related samples Wilcoxon Signed-Rank Test was utilized to examine if
significant differences occurred in cardiovascular endurance, muscular strength, and
fatigue. The following dependent variables were assessed: VO2peak, EST 1-RM leg press,
EST 1-RM chest press, EST 1-RM seated row, EST 1-RM lat pull down, EST 1-RM
shoulder press and fatigue. With the low number of participants, pre and post results of
all completed phases were compared. Statistical analyses were performed using the
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Statistical Package for the Social Science software package (SPSS, Chicago, IL).
Significance levels were set at p < 0.05.
Results
The purpose of this study was to determine if the UNCCRI Phase Program was
more effective in a group model setting or in a one-on-one setting. Effectiveness was
evaluated by determining changes in cardiorespiratory endurance, muscular strength, and
cancer-related fatigue. Establishing a cancer rehabilitation model that can be
administrated in an individual and group setting could provide adaptability for clinics and
hospitals administrating a cancer rehabilitation program. By creating a structured cancerspecific group model that can produce results similar to the one-on-one model, a feasible
rehabilitation program for the large number of cancer survivors could be provided. It was
hypothesized that the Phase Training Cancer Rehabilitation Program is more effective
with a one-on-one model when compared to a group model.
Table 2 summarizes the demographic characteristics of study participants. A total
of 14 cancer survivors were recruited to participate in the group study. Of the fourteen,
12 completed the program (seven males and five females). The treatments the
participants received prior to or during the program included: surgery only, radiation
only, combination of surgery and chemotherapy, combination of surgery and radiation,
and the combination of surgery, radiation, and chemotherapy. The attendance rate for the
exercise programs sessions throughout the study was 71%. After participants completed
a Phase there was a 75% retention rate for continuing the Phase Training Model GM. On
average each participant completed eight strength exercises during each exercise session.
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This number of completed exercises meets the ACSM recommendations of completing
eight to ten different exercises within a session.
Table 2
Participants Characteristics
Participant Characteristics

N=12

Age (years)
Male, n (%)

68 ± 12
7 (58)

Female, n (%)

5 (42)

Height (Inches)
Weight (pounds)

67 ± 4
160 ± 19

Phase

N (%)

Phase 1
Phase 2
Phase 3

2 (17)
6 (50)
4 (33)

Cancer Type

N (%)

Breast
Prostate
Colorectal

1 (8)
4 (34)
3 (25)

Uterine
Melanoma

3 (25)
1 (8)

Cancer Stage

N (%)

I
II
III
IV
Unknown/not staged

1 (8)
4 (34)
3 (25)
3 (25)
1 (8)

Changes in Peak Volume of Oxygen
Consumption, Muscular Strength,
and Fatigue in Group Model
Table 3 depicts absolute values (pre-to-post) for the GM for VO2peak (mLkg1

min-1), leg press MS (pounds lifted), chest press MS, seated row MS, shoulder press

MS, and fatigue. Figure 1 depicts mean percent change in VO2peak and fatigue. Figure 2
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depicts pre to post strength differences for lower and upper body, while figure 3 depicts
mean percent changes in lower body and upper body strength.
After completing a twelve week intervention in the GM, significant improvements
(p<0.05) were observed in VO2peak (mLkg-1min-1), leg press MS, chest press MS, seated
row MS, and shoulder press MS, and fatigue. Non-significant improvements (p>0.05)
were observed in lat pull down MS, leg extension MS, and leg curl MS. Figure 8 depicts
the percent change for each variable was as follows: VO2peak (9%), leg press MS (10%),
chest press MS (16%), seated row MS (11%), shoulder press MS (18%) and fatigue
(-36%).
Table 3
Improvements in Physiological Values and Fatigue
Group Model
Strength Variables

N=12

VO2peak
Leg Press MS

19.1
172

Pre
± 4.0
± 66

Leg Curl MS
Leg Extension MS
Chest Press MS
Seated Row MS
Lat Pull down MS
Shoulder Press MS

80
114
64
90
108
45

±
±
±
±
±
±

33
27
33
33
35
16

Fatigue

4.9

±

1.1

21.1
190
85
131
77
101
115
54

Post
± 3.9*
± 81*
± 39
± 38
± 38*
± 33*
± 35
± 13*

± 2.0*
3.1
Note. N = number of participants, VO2peak = peak volume of oxygen consumption
(mL·kg-1·min-1); MS = muscular strength (pounds lifted), * denotes a p value < 0.05
between pre and post values.
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Percent Change in VO2peak and Fatigue
20
10

*

% Change

0
VO2 Peak

-10

Fatigue

-20
-30

*

-40

Figure 1. Mean percent change in VO2peak and fatigue pre to post each phase transition
in the GM. *p < 0.05

Muscular Strength Changes Pre and Post
200

*

Weight Lifted in Punds (lbs)

180
160

140
120
*

100

Pre

*

80

Post

60

*

40
20
0
Leg Press

Chest Press

Seated Row

Shoulder Press

Figure 2. Muscular strength changes with each Phase transition in the GM.
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Percent Change in Muscular Strength
20
*

18
*

16

% Change

14
12
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*

*

8
6
4

2
0
Leg Press

Chest Press

Seated Row

Shoulder Press

Figure 3. Mean percent change in upper and lower body strength between each Phase
transition; *p < 0.05
Individual vs. Group Phase Training Models
The twelve participants of the GM completed Phase 1, Phase 2 and Phase 3 of the
GM. When comparing the results of the Individual Phase Training Model (IM) to the
GM we evaluated all of the Phase transitions completed by the participants. The GM had
a significantly lower N than the compared IM making the IM results more significant
than the GM. Figure 4 depicts the mean percent change in VO2peak and strength between
the IM compared to the GM. Figure 5 depicts the mean percent change in fatigue
between the IM and GM Phase Training Model. When determining the mean values for
the IM, the average was determined from the combining the average percentages from
each phase transition, Phase I to Phase II, Phase II to Phase III, and Phase III to
completion of the program.
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Although the GM was a pilot study and had drastically lower number of
participants, similar results between GM and the IM Phase Training Model were
observed in all variables. When observing the changes in fatigue classification, five
participants stayed within the moderate category although their fatigue score decreases,
six participants went from moderate to mild, and one participant went from mild to none
in fatigue classification.

Percent Change in VO2Peak and Strength
Individual vs. Group
18
16
14

% Change

12
10

One-on-one

8

Group

6
4
2
0
VO2Peak

Leg Press

Chest Press

Figure 4. Comparison between the individual and group model in percent change in
VO2peak and Strength
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Percent Change in Fatigue
Individual vs. Group
0
-5

% Change in Fatigue

-10
-15
One-on-one

-20

Group

-25
-30
-35
-40

Figure 5. Mean percent change in fatigue between the one-on-one and group model
Discussion
To date, the Phase Training Model introduced by Brown (2016) is the only
established structured model for cancer rehabilitation that includes mode, intensity,
frequency and duration for cancer survivors. The main attributes to the success of the
Phase Training Model is the cancer specific fitness assessments utilized to create a
detailed and individualized exercise prescription for each participant. This study
indicates that the Phase Training Model can be effectively administered in an individual
or group model. The GM produced significant improvements in cardiovascular fitness,
upper and lower body muscular strength, and fatigue throughout all phases of the
program. An important take away from this study is that a group design is safe, effective,
and well tolerated for all cancer patients regardless of diagnosed cancer stage and
treatment status. In this study, six participants were able to complete one or more Phases
of the group program with cancer stage diagnosis of three or four. The group model also
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shows to be well-tolerated for patients who are currently undergoing treatment. This
supports Brown (2016) findings that Phase one’s intensity is safe and effective in
producing significant psychological and physiological improvements, and should become
the standard intervention for patients undergoing treatment. This study indicates that
when using the same assessments and guidelines for exercise prescription as the Phase
Training Model protocol, it is safe and well tolerated for any cancer patient whether the
program is administrated individually or in a group.
Group vs Individual
The GM yielded similar results to the other group studies as well as the IM Phase
Training Model. With the small number of participants in the pilot study of the GM,
Phase-to-Phase transitions could not be compared to the IM Phase Training Model.
Comparing the IM Phase Training Model to the GM the results are very similar when
evaluating the overall improvements of the total program. When comparing the mean
percent change in VO2peak and strength in participants completing Phase one and two, the
results are very similar between the participants completing the IM and GM. Participants
completing the IM resulted in an average 10.8% increase in VO2peak, while the GM
resulted in an average 9.4% increase. Participant’s leg press strength increased by an
average of 8.9% in the IM compared to an average 10.3% increase in the GM.
Participant’s chest press strength increased by an average of 15.6% in the IM, in
comparison to an average 16.5% increase in the GM. The mean percent change in
fatigue for participants completing the IM was a 20.7% decrease, while the GM
experienced a 36% decrease in fatigue. The only outcome that was lower in the GM than
the IM was cardiovascular endurance. The smaller increase in cardiovascular endurance,
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although still significant, can be attributed to two main disadvantages of the GM. One
disadvantage is not having the ability to use heart rate in the participants exercise
prescription. The disadvantage of using RPE for the cardiovascular portion of the
exercise session is that it can change daily within cancer patients depending on the side
effects cancer treatment toxicities that can have an impact on fatigue, pain, and mental
state. The second disadvantage of the GM is the lack of constant encouragement,
motivation, and supervision of the CES which is provided in the IM. In some cases the
prescribed intensity for an individual to reach their target heart rate and RPE can be quite
challenging. Without a CES by their side to help push them to the prescribed intensity
participants have a hard time reaching the prescribed heart rate zone. Due to this a
participant suffering from severe cardio toxicities would benefit greater in the IM Phase
Training Model than the GM. The greatest difference in the results between the IM and
the GM was fatigue. With administrating the same exercise intensity ranges for
participants in each Phase, the greater decrease in fatigue seen in GM can be attributed to
working within the group. Although the GM had a smaller N than the IM compared to,
the similar results between the IM and the GM, demonstrates how versatile the Phase
Training Model can be for clinics and hospitals.
In recent studies group exercise models have included additional services such as
support groups or team activities to the exercise program to enhance group cohesion
(Dittus et al 2015; May et al. 2008, Midtgaard et al 2006). It has been established that
group cohesion can produce positive effects on program outcomes (May et al. 2008).
This is the first study where the group model is only based on exercise prescription and
does not include any additional services. Although the study did not include additional
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services and only focused on exercise, there were still significant improvements seen in
participant’s psychological factors, such as cancer related fatigue. This indicates that
group exercise alone may have a positive effect on the negative psychological effects of
cancer diagnosis and treatment. Although there were no additional services offered to the
participants in the Phase Training Group Model, participants had the opportunity to
socialize throughout their exercise intervention, where they were able to get to know each
other and create a sense of group cohesion. This indicates that group cohesion may not
need to be administered in additional services but rather having cancer survivors working
out in the same facility creates a group aspect all on its own.
The largest limitation of this study was the number of participants allowing us to
only present this study as a pilot. UNCCRI plans to continue this study to collect enough
data to be able to compare the Phase Training Model side by side to the UNCCRI Group
Model. One limitation the GM experienced from the IM was not being able to use heart
rate percentages in the exercise prescription. Without the use of heart rate monitors
participants were asked to exercise at a prescribed RPE. This type of prescription is less
accurate than heart rate because RPE can differ greatly in cancer survivors on a day-today basis. This difference in prescription could be the primary reason the IM resulted in
better cardiovascular endurance results than the GM.
The largest barriers for cancer patients to receive rehabilitation through exercise
interventions are the cost and the lack of exercise facilities tailored to the cancer
population (Blaney et al. 2010). With patients unable to receive re-imbursement from
insurance, the financial burden is put on the cancer survivor needing these services.
Research has indicated that exercise can have powerful effects on decreasing the negative
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side effects experienced after and during cancer treatment. By establishing a group
exercise rehabilitation program created specifically for cancer patients during any aspect
of the survivor continuum, more cancer patients can have access to a valuable onedimensional rehabilitation program through exercise interventions without the financial
burden. By demonstrating the Phase Training Model protocol can be safe and effective
within a GM, it should be established as the standard rehabilitation program for cancer
patients within the hospital and clinical setting.
Conclusion
To date, the Cancer Phase Training Model is the only cancer rehabilitation
intervention that includes recommended modes, intensity, frequency, and duration of
exercise for cancer survivors. Through the precise cancer-specific pretreatment
screening, baseline fitness assessment, and individualize exercise prescription, the Cancer
Phase Training Model has been shown to attenuate the negative physiological and
psychological effects of cancer treatment. This pilot study indicates that the Phase
Training Model protocol can be safely and effectively administrated in a group model.
Through administrating the Phase Training Program in a group model, professionals can
have a greater impact by providing services to more cancer survivors without placing the
financial burden on the survivor or the program provider. By demonstrating its diversity,
the Phase Training Model should be considered as a standard of care in the clinical
cancer rehabilitation setting considering its success in both the group and individual
model.
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